產品資訊 - Hepatitis C Virus Core Antigen Detection Kit->aspalthic products

登入

加入會員

求助

HunanRunkunPharmaceuticalCo.,Ltd.

	Recommended Results

Hepatitis C Virus Core Antigen Detection Kit

產品分類 :

化學->化學用品->aspalthic products

Hepatitis C Virus Core Antigen Detection Kit

產品規格

Country	CN
Brand	RunKun
Packing	carton
Payment Term	T/T,Paypal,Western Union

產品描述

Hepatitis C virus (HCV) core antigen detection kit is an HCV antigen
diagnostic reagent which is a world-recognizing pioneering product in
China. It was jointly designed and developed by Hunan Jingda
Pharmaceutical Co. Ltd. and the Institute of Basic Medical Sciences
under the Academy of Military Medical Sciences of the Chinese People's
Liberation Army. Based on the analysis of different gene subtypes' core
antigen sequences of HCV, conservative antigen amino acid sequences with
similarity and strong antigenicity could be defined. Monoclonal
antibody cells against different parts of core antigen sequences were
developed for product anti-HCV core antibody with high affinity binding
and specificity. What is more, through the functional matching of these
monoclonal antibody cells, HCV core antigen detection kit could be
produced with the adoption of double antibody sandwich ELISA. 
 
 Product Features 
 
 1. The sensitivity for detection is nearly as high as that of HCV-RNA. 
 2. The whole operation process is the same as the conventional ELISA. No special instrument or equipment is needed. 
 3. The infectious "window period" of HCV could be reduced to two weeks
which is about 35 days on average shorter than commonly used antigen
diagnostic reagent in the market. 
 4. There is no special requirement for samples of serum or plasma. 
 
 
<img src="http://www.runkun.cc/enimages/proopen2.jpg" /> 
 

 


Significance of Promotion


This kit can help directly detect HCV antigen when the human body was
infected with HCV, so it can significantly shorten the "window period"
(70 days) of commonly used antigen diagnostic reagent at present. This
product is mainly used for HCV routine in clinical laboratories in
hospitals, blood screening in blood stations and blood products, and in
monitoring of HCV viremiain medical institutions during the treatment of
hepatitis C.

 
 1) Early diagnosis of HCV 
 2) Auxiliary diagnosis of acute and chronic hepatitis C 
 3) Monitoring of HCV viremia before and after treatment of patients with hepatitis C 
 4) Blood screening 
 
 Hepatitis C is the most common viral hepatitis caused by blood
transfusion and accounts for about 90% of post-transfusion hepatitis.
Most of hepatitis C patients are infected during the "window period".runkun-med.com

其他類似產品